Litcius/Paper detail

Sitagliptin ameliorates hypoxia-induced damages in endometrial stromal cells: an implication in endometriosis

Ying Li, Xiaolin Lv, Mei Jiang, Zhili Jin

2021Bioengineered17 citationsDOIOpen Access PDF

Abstract

), and high mobility group box (HMGB)-1, in hypoxia-treated HESCs were pronouncedly repressed by Sitagliptin. The activated p38 mitogen-activated protein kinases (MAPK) pathway was observed in hypoxia-stimulated HESCs, then greatly inhibited by the introduction of Sitagliptin. Lastly, hypoxia-induced phosphorylation and degradation of IκBα, as well as the upregulation of nuclear factor kappa-B (NF-κB) p65 and increased transcriptional activity of NF-κB, were dramatically abolished by Sitagliptin. Collectively, Sitagliptin ameliorated hypoxia-induced damages in ESCs by suppressing the inflammation.

Topics & Concepts

SitagliptinHypoxia (environmental)InflammationOxidative stressTumor necrosis factor alphaStromal cellEndocrinologyInternal medicineChemistryCancer researchMedicineType 2 diabetesDiabetes mellitusOrganic chemistryOxygenEndometriosis Research and TreatmentReproductive System and PregnancyEstrogen and related hormone effects